Pathogenic mutation in VPS35 impairs its protection against MPP+ cytotoxicity

International Journal of Biological Sciences

Volumn 9, Issue 2, 2013, Pages 149-155

  Bi, Fangfang ^a   Li, Fang ^a   Huang, Cao ^a   Zhou, Hongxia ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

1 methyl 4 phenylpyridinium; Parkinson's disease; Vacuolar protein sorting 35; Vps35

Indexed keywords

EID: 84873723060     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.5617     Document Type: Article

References (28)

1. Schulz JB. Mechanisms of neurodegeneration in idiopathic Parkinson's disease. Parkinsonism Relat Disord 13 Suppl 2007;3: S306-308.
2. Xia XG, Schmidt N, Teismann P, Ferger B, and Schulz JB. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation. J Neurochem 2001;79: 63-70.
3. Xia XG, Harding T, Weller M, Bieneman A, Uney JB, and Schulz JB. Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A 2001;98: 10433-10438.
4. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, et al. Mu-tation in the alpha- synuclein gene identified in families with Parkinson's disease. Science 1997;276: 2045-2047.
5. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, and Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392: 605-608.
6. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003;299: 256-259.
7. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004;304: 1158-1160.
8. Zimprich A, Biskup S, Leitner P, Licht-ner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44: 601-607.
9. Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez de, Munain A, Aparicio S, Gil AM, Khan N, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004;44: 595-600.
10. Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, Jenkins NA, Price DL, and Lee MK. Parkinson's disease al-pha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 2006;26: 41-50.
11. Tian T, Huang C, Tong J, Yang M, Zhou H, and Xia XG. TDP-43 Potentiates Alpha-synuclein Toxicity to Dopaminergic Neurons in Transgenic Mice. Int J Biol Sci 2011;7: 234-243.
12. Zimprich A, Benet-Pages A, Struhal W, Graf E, Eck SH, Offman MN, Hau-benberger D, Spielberger S, Schulte EC, Lichtner P, et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet 2011;89: 168-175.
13. Vilarino-Guell C, Wider C, Ross O.A, Dachsel JC, Kachergus JM, Lincoln SJ, Soto-Ortolaza AI, Cobb SA, Wilhoite GJ, Bacon JA, et al. VPS35 mutations in Par-kinson disease. Am J Hum Genet 2011;89: 162-167.
14. Wen L, Tang FL, Hong Y, Luo SW, Wang CL, He W, Shen C, Jung JU, Xiong F, Lee DH, et al. VPS35 haploinsufficiency increases Alzheimer's disease neuropathology. J Cell Biol 2011;195: 765-779.
15. Lee JJ, Radice G, Perkins C.P, and Costantini F. Identification and characteri- zation of a novel, evolutionarily conserved gene disrupted by the murine H beta 58 embryonic lethal transgene insertion. De-velopment 1992;115: 277-288.
16. Collins BM, Skinner CF, Watson PJ, Seaman MN, and Owen DJ. Vps29 has a phosphoesterase fold that acts as a protein interaction scaffold for retromer assembly. Nat Struct Mol Biol 2005;12: 594-602.
17. Braschi E, Goyon V, Zunino R, Mo-hanty A, Xu L, and McBride HM. Vps35 mediates vesicle transport between the mitochondria and peroxisomes. Curr Biol 2010;20: 1310-1315.
18. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, and Guo M. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature. 2006;441: 1162-1166.
19. Zhou H, Falkenburger BH, Schulz JB, Tieu K, Xu Z, and Xia XG. Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice. Int J Biol Sci 2007;3: 242-250.
20. Jenner P. The contribution of the MPTP-treated primate model to the devel-opment of new treatment strategies for Parkinson's disease. Parkinsonism Relat Disord 2003;9: 131-137.
21. Dawson T, Mandir A, and Lee M. Animal models of PD: pieces of the same puzzle? Neuron 2002;35: 219-222.
22. Szego EM, Outeiro TF, Kermer P, and Schulz JB. Impairment of the septal cho-linergic neurons in MPTP-treated A30P al-pha-synuclein mice. Neurobiol Aging 2013;34: 589-601.
23. Cui M, Tang X, Christian WV, Yoon Y, and Tieu K. Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1. J Biol Chem 2010;285: 11740-11752.
24. Xia XG, Zhou H, Samper E, Melov S, and Xu Z. Pol II-expressed shRNA knocks down Sod2 gene expression and causes phenotypes of the gene knockout in mice. PLoS Genet 2006;2: 27.
25. Xia XG, Zhou H, Zhou S, Yu Y, Wu R, and Xu Z. An RNAi strategy for treatment of amyotrophic lateral sclerosis caused by mutant Cu,Zn superoxide dismutase. J Neurochem 2005;92: 362-367.
26. Schneider JS, Huang FN, and Vemuri MC. Effects of low-level lead exposure on cell survival and neurite length in primary mesencephalic cultures. Neurotoxicol Teratol 2003;25: 555-559.
27. Small SA, Kent K, Pierce A, Leung C, Kang MS, Okada H, Honig L, Vonsattel JP, and Kim TW. Model-guided microarray implicates the retromer complex in Alzheimer's disease. Ann Neurol 2005;58: 909-919.
28. Huang C, Tong J, Bi F, Wu Q, Huang B, Zhou H, and Xia XG. Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats. Hum Mol Genet 2012;21: 4602-4614.